These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy. Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122 [TBL] [Abstract][Full Text] [Related]
6. A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. Nagatomo Y; Yoshikawa T; Kohno T; Yoshizawa A; Baba A; Anzai T; Meguro T; Satoh T; Ogawa S J Card Fail; 2009 Apr; 15(3):224-32. PubMed ID: 19327624 [TBL] [Abstract][Full Text] [Related]
7. Presence of autoantibody directed against β1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study. Nagatomo Y; Yoshikawa T; Okamoto H; Kitabatake A; Hori M; J Card Fail; 2015 Mar; 21(3):198-207. PubMed ID: 25528200 [TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Müller J; Wallukat G; Dandel M; Bieda H; Brandes K; Spiegelsberger S; Nissen E; Kunze R; Hetzer R Circulation; 2000 Feb; 101(4):385-91. PubMed ID: 10653829 [TBL] [Abstract][Full Text] [Related]
9. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function. Michelucci A; D'Elios MM; Sticchi E; Pieragnoli P; Ricciardi G; Fatini C; Benagiano M; Niccolai E; Grassi A; Attanà P; Nesti M; Grifoni G; Padeletti L; Abbate R; Prisco D Pacing Clin Electrophysiol; 2016 Jan; 39(1):65-72. PubMed ID: 26411359 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates. Warraich RS; Noutsias M; Kazak I; Seeberg B; Dunn MJ; Schultheiss HP; Yacoub MH; Kuhl U Am Heart J; 2002 Jun; 143(6):1076-84. PubMed ID: 12075266 [TBL] [Abstract][Full Text] [Related]
12. [Temporary mechanical left heart support. Recovery of heart function in patients with end-stage idiopathic dilated cardiomyopathy]. Müller J; Wallukat G; Weng YG; Dandel M; Spiegelsberger S; Semrau S; Brandes K; Bieda H; Hummel M; Loebe M; Meyer R; Hetzer R Herz; 1997 Oct; 22(5):227-36. PubMed ID: 9441154 [TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus. Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316 [TBL] [Abstract][Full Text] [Related]
14. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure. Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286 [TBL] [Abstract][Full Text] [Related]
15. A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease. Bornholz B; Benninghaus T; Reinke Y; Felix SB; Roggenbuck D; Jahns-Boivin V; Jahns R; Boege F Clin Chem Lab Med; 2016 Apr; 54(4):683-91. PubMed ID: 26408610 [TBL] [Abstract][Full Text] [Related]
16. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol. Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464 [TBL] [Abstract][Full Text] [Related]
17. [Serum autoantibodies against the cardiac beta(1)-adrenergic receptor in patients with chronic heart failure: clinical characteristics and response to carvedilol]. Chen J; Yang XC; Wang SY; Zhu JG; Liu XL; Wu YF; Zhang L Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):599-602. PubMed ID: 17961421 [TBL] [Abstract][Full Text] [Related]
18. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment. Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043 [TBL] [Abstract][Full Text] [Related]
19. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Müller J; Wallukat G; Weng YG; Dandel M; Spiegelsberger S; Semrau S; Brandes K; Theodoridis V; Loebe M; Meyer R; Hetzer R Circulation; 1997 Jul; 96(2):542-9. PubMed ID: 9244223 [TBL] [Abstract][Full Text] [Related]